Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 9

Results: 19

AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1598, doi. 10.1038/leu.2009.104

By:

Jiao, B.;
Wu, C.-F.;
Liang, Y.;
Chen, H.-M.;
Xiong, S.-M.;
Chen, B.;
Shi, J.-Y.;
Wang, Y.-Y.;
Wang, J.-H.;
Chen, Y.;
Li, J.-M.;
Gu, L.-J.;
Tang, J.-Y.;
Shen, Z.-X.;
Gu, B.-W.;
Zhao, W.-L.;
Chen, Z.;
Chen, S.-J.

Publication type:

Article

Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.

Published in:

2009

By:

Hochhaus, A.;
Müller, M. C.;
Radich, J.;
Branford, S.;
Kantarjian, H. M.;
Hanfstein, B.;
Rousselot, P.;
Kim, D.-W.;
Lipton, J. H.;
Bleickardt, E.;
Lambert, A.;
Hughes, T. P.;
Müller, M C

Publication type:

journal article

The role of monocytes-macrophages in vasculogenesis in multiple myeloma.

Published in:

2009

By:

Ribatti, D.;
Vacca, A.

Publication type:

Editorial

The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1614, doi. 10.1038/leu.2009.69

By:

Mian, A. A.;
Schüll, M.;
Zhao, Z.;
Oancea, C.;
Hundertmark, A.;
Beissert, T.;
Ottmann, O. G.;
Ruthardt, M.

Publication type:

Article

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1634, doi. 10.1038/leu.2009.70

By:

Weber, G.;
Karbach, J.;
Kuçi, S.;
Kreyenberg, H.;
Willasch, A.;
Koscielniak, E.;
Tonn, T.;
Klingebiel, T.;
Wels, W. S.;
Jäger, E.;
Bader, P.

Publication type:

Article

BCR–ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1622, doi. 10.1038/leu.2009.74

By:

Kobayashi, S.;
Kimura, F.;
Ikeda, T.;
Osawa, Y.;
Torikai, H.;
Kobayashi, A.;
Sato, K.;
Motoyoshi, K.

Publication type:

Article

Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1643, doi. 10.1038/leu.2009.76

By:

Bebawy, M.;
Combes, V.;
Lee, E.;
Jaiswal, R.;
Gong, J.;
Bonhoure, A.;
Grau, G. E. R.

Publication type:

Article

Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1650, doi. 10.1038/leu.2009.78

By:

Qian, Z.;
Mao, L.;
Fernald, A. A.;
Yu, H.;
Luo, R.;
Jiang, Y.;
Anastasi, J.;
Valk, P. J.;
Delwel, R.;
Le Beau, M. M.

Publication type:

Article

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.

Published in:

2009

By:

Heinrichs, S.;
Kulkarni, R. V.;
Bueso-Ramos, C. E.;
Levine, R. L.;
Loh, M. L.;
Li, C.;
Neuberg, D.;
Kornblau, S. M.;
Issa, J.-P.;
Gilliland, D. G.;
Garcia-Manero, G.;
Kantarjian, H. M.;
Estey, E. H.;
Look, A. T.

Publication type:

journal article

Ascorbic acid inhibits antitumor activity of bortezomib in vivo.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1679, doi. 10.1038/leu.2009.83

By:

Perrone, G.;
Hideshima, T.;
Ikeda, H.;
Okawa, Y.;
Calabrese, E.;
Gorgun, G.;
Santo, L.;
Cirstea, D.;
Raje, N.;
Chauhan, D.;
Baccarani, M.;
Cavo, M.;
Anderson, K. C.

Publication type:

Article

Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1577, doi. 10.1038/leu.2009.85

By:

Wang, J.;
Ishii, T.;
Zhang, W.;
Sozer, S.;
Dai, Y.;
Mascarenhas, J.;
Najfeld, V.;
Zhao, Z. J.;
Hoffman, R.;
Wisch, N.;
Xu, M.

Publication type:

Article

Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1658, doi. 10.1038/leu.2009.86

By:

Valencia, A.;
Román-Gómez, J.;
Cervera, J.;
Such, E.;
Barragán, E.;
Bolufer, P.;
Moscardó, F.;
Sanz, G. F.;
Sanz, M. A.

Publication type:

Article

Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia.

Published in:

2009

By:

Cortes, J. E.;
Egorin, M. J.;
Guilhot, F.;
Molimard, M.;
Mahon, F.-X.

Publication type:

journal article

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.

Published in:

2009

By:

Coppo, P.;
Gouilleux-Gruart, V.;
Huang, Y.;
Bouhlal, H.;
Bouamar, H.;
Bouchet, S.;
Perrot, C.;
Vieillard, V.;
Dartigues, P.;
Gaulard, P.;
Agbalika, F.;
Douay, L.;
Lassoued, K.;
Gorin, N.-C.

Publication type:

journal article

Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.

Published in:

2009

By:

Renouf, B.;
Hollville, É;
Pujals, A.;
Tétaud, C.;
Garibal, J.;
Wiels, J.;
Hollville, E;
Tétaud, C

Publication type:

journal article

A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1564, doi. 10.1038/leu.2009.94

By:

Ikezoe, T.;
Yang, J.;
Nishioka, C.;
Takezaki, Y.;
Tasaka, T.;
Togitani, K.;
Koeffler, H. P.;
Yokoyama, A.

Publication type:

Article

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.

Published in:

2009

By:

Visani, G.;
Piccaluga, P.;
Malagola, M.;
Isidori, A.

Publication type:

Case Study

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1545, doi. 10.1038/leu.2009.89

By:

Dimopoulos, M.;
Terpos, E.;
Comenzo, R. L.;
Tosi, P.;
Beksac, M.;
Sezer, O.;
Siegel, D.;
Lokhorst, H.;
Kumar, S.;
Rajkumar, S. V.;
Niesvizky, R.;
Moulopoulos, L. A.;
Durie, B. G. M.

Publication type:

Article

Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.

Published in:

Leukemia (08876924), 2009, v. 23, n. 9, p. 1587, doi. 10.1038/leu.2009.99

By:

Korver, W.;
Zhao, X.;
Singh, S.;
Pardoux, C.;
Zhao, J.;
Guzman, M. L.;
Sen, S.;
Yonkovich, S.;
Liu, S.;
Zhan, X.;
Tomasevic, N.;
Zhou, C.;
Gros, D.;
Jordan, C. T.;
Gotlib, J.;
Hsi, E. D.;
Abo, A.

Publication type:

Article